Class information for:
Level 1: HYBRIDIZATION TECHNOLOGY//IMMUNOLIGAND ASSAY//BIOASSAY GRP

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
32825 102 22.2 48%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2348 3955 PHOSPHOLIPIDOSIS//2 DEOXYSTREPTAMINE//AMINOGLYCOSIDES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 HYBRIDIZATION TECHNOLOGY Author keyword 1 100% 2% 2
2 IMMUNOLIGAND ASSAY Author keyword 1 100% 2% 2
3 BIOASSAY GRP Address 1 50% 1% 1
4 CAS 105857 23 6 Author keyword 1 50% 1% 1
5 E COLI HOST CELL PROTEINS Author keyword 1 50% 1% 1
6 ESCHERICHIA COLI ANTIGEN Author keyword 1 50% 1% 1
7 ANTI BACTERIUM Author keyword 0 33% 1% 1
8 CLINICAL CONSIDERATIONS Author keyword 0 33% 1% 1
9 PROTEIN PHARMACEUTICAL Author keyword 0 33% 1% 1
10 SYMBIOFLOR R 1 Author keyword 0 33% 1% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 HYBRIDIZATION TECHNOLOGY 1 100% 2% 2 Search HYBRIDIZATION+TECHNOLOGY Search HYBRIDIZATION+TECHNOLOGY
2 IMMUNOLIGAND ASSAY 1 100% 2% 2 Search IMMUNOLIGAND+ASSAY Search IMMUNOLIGAND+ASSAY
3 CAS 105857 23 6 1 50% 1% 1 Search CAS+105857+23+6 Search CAS+105857+23+6
4 E COLI HOST CELL PROTEINS 1 50% 1% 1 Search E+COLI+HOST+CELL+PROTEINS Search E+COLI+HOST+CELL+PROTEINS
5 ESCHERICHIA COLI ANTIGEN 1 50% 1% 1 Search ESCHERICHIA+COLI+ANTIGEN Search ESCHERICHIA+COLI+ANTIGEN
6 ANTI BACTERIUM 0 33% 1% 1 Search ANTI+BACTERIUM Search ANTI+BACTERIUM
7 CLINICAL CONSIDERATIONS 0 33% 1% 1 Search CLINICAL+CONSIDERATIONS Search CLINICAL+CONSIDERATIONS
8 PROTEIN PHARMACEUTICAL 0 33% 1% 1 Search PROTEIN+PHARMACEUTICAL Search PROTEIN+PHARMACEUTICAL
9 SYMBIOFLOR R 1 0 33% 1% 1 Search SYMBIOFLOR+R+1 Search SYMBIOFLOR+R+1
10 TISSUE PLASMINOGEN ACTIVATOR RECOMBINANT 0 33% 1% 1 Search TISSUE+PLASMINOGEN+ACTIVATOR++RECOMBINANT Search TISSUE+PLASMINOGEN+ACTIVATOR++RECOMBINANT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOTECHNOLOGY PRODUCT VALIDATION 0 25% 1% 1
2 HEPATITIS B VACCINES 0 13% 2% 2
3 PROTEIN IMPURITIES 0 20% 1% 1
4 THERAPEUTIC PRODUCTS 0 13% 1% 1
5 PASSIVELY ADMINISTERED ANTIBODY 0 11% 1% 1
6 TETANUS TOXIN ANTIGEN 0 11% 1% 1
7 BIOASSAY DEVICE 0 100% 1% 1

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
FDA regulatory reform 1997 3 3 67%
Progress in the use of biological assays during the development of biotechnology products 2001 13 21 24%
IMPROVEMENT AND EXPERIMENTAL VALIDATION OF PROTEIN IMPURITY IMMUNOASSAYS FOR RECOMBINANT-DNA PRODUCTS 1990 7 14 36%
MANUFACTURE OF BIOPHARMACEUTICAL PROTEINS BY MAMMALIAN-CELL CULTURE SYSTEMS 1990 2 4 50%
VIRUS-VACCINES - 1986 UPDATE 1986 5 1 100%
SENSITIVE DETECTION AND QUANTITATION OF PROTEIN CONTAMINANTS IN RDNA PRODUCTS 1988 0 6 67%
BIOSAFETY CONSIDERATIONS IN INDUSTRIES WITH PRODUCTION METHODS BASED ON THE USE OF RECOMBINANT DEOXYRIBONUCLEIC-ACID 1990 4 17 12%
DEVELOPING RESEARCH TRENDS IN THE CHEMISTRY OF PLANT-RESISTANCE TO PESTS 1986 2 7 29%
Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens 2005 27 109 3%
NEW BIOTECHNOLOGY AS A LOGICAL OUTGROWTH OF MOLECULAR-BIOLOGY 1986 1 50 8%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 BIOASSAY GRP 1 50% 1.0% 1
2 BIOL EVALUAT CYTOKINE BIOL 0 25% 1.0% 1
3 BAMD GRP 0 100% 1.0% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000248041 TROSPECTOMYCIN//CLIN SCI AGR PRACTICES//ANAEROBIC SUSCEPTIBILITY
2 0.0000096658 SALMONELLA ZENTRALE//URIDINE DIPHOSPHOGLUCURONYL TRANSFERASE//BUNDES INFEKTIONSKRANKHEITEN NICHT UBERTRAG
3 0.0000093878 NASAL AIRFLOW//SAUL A SILVERMAN FAMILY FDN//VA1 RNA
4 0.0000092624 FOOD CONTACT REGULATION//TOXICITY ASSESSMENT OF TREATED WASTEWATER//EEC DIRECTIVES
5 0.0000086715 BOVINE HIPPOCAMPUS//SEROTONIN1A RECEPTOR//P MPPF
6 0.0000080293 20K HGH//22K HGH//GH ABUSE
7 0.0000076833 ALTERNATING POISSON PROCESS//ALTERNATING RENEWAL//PRODUCTION CYCLE TIME
8 0.0000075320 RALSTONIA PICKETTII//BREVUNDIMONAS DIMINUTA//FILTER VALIDATION
9 0.0000072800 CO OPERATIVE GOVERNMENT//CONSTITUTIONAL SUPREMACY//HOUSING DERIVATIVES
10 0.0000062368 TGN1412//SAFETY PHARMACOLOGY//REPEAT DOSE TOXICITY STUDIES